Cases discuss patients with medication allergies and drug interactions.
Pharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Examining the clinical applications, effectiveness, safety, and regulation of herbal supplements with a focus on the role of pharmacists.
There are a number of ways in which job design and working conditions can be improved in the community pharmacy setting, either on the store level or on an organization-wide basis.
These disorders can be fatal, making pharmacists’ role in detection crucial.
Tapping their specific skill sets and training can help serve patients more effectively, although challenges exist.
Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.
As pharmacists provide more health care services, opportunities arise for more sophisticated patient engagement and billing solutions that drive patient satisfaction and increased loyalty.
Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.
Panelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.
Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.
On the heels of Women Pharmacist Day on October 12, we highlight 3 female pharmacists who have followed unique career paths that help to drive innovation and change in the industry, beyond the retail pharmacy setting.
Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.
Medically integrated pharmacies improve collaboration, patient care, communication, and therapy management.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Axatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.
Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.
Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.
The adjuvant therapy has demonstrated varied efficacy for patients.
IMROZ study data show Isa-VRd may be a new standard of care.
Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.
Despite Muslim patients’ need for halal medication, more than 80% of pharmacists were found to lack knowledge about where to look to find alternative medications that are halal.
With health systems undergoing a necessary reevaluation of how they allocate their funding into the future, initial data support the need for them to offer a hospital-at-home option for patients they serve.
The use of adulterated cannabinoids mixed with insecticides is becoming more common.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Although COVID-19 paused our original plans, we were ultimately able to reach more people than we ever could have via in-person presentations alone.